Bioceltix S.A. Logo

Bioceltix S.A.

Develops stem cell-based medicinal products for veterinary use.

BCX | WAR

Overview

Corporate Details

ISIN(s):
PLBCLTX00019 (+1 more)
LEI:
259400QZD5JYK8SLZU51
Country:
Poland
Address:
Wrocław Bierutowska 57-59/BUD.III, 51-317 Wrocław

Description

Bioceltix S.A. is a biopharmaceutical company that develops stem cell-based medicinal products for veterinary use. The company focuses on creating therapies that utilize Mesenchymal Stem Cells (MSCs) as the active pharmaceutical ingredient. Its product pipeline is aimed at treating immunological and inflammatory conditions in companion animals, including dogs, cats, and horses. A key area of development includes treatments for conditions such as atopic dermatitis in dogs and degenerative joint disease.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-19 07:25
Tekst jednolity statutu Spółki
Polish 355.6 KB
2025-12-19 07:25
Rejestracja podwyższenia kapitału zakładowego i zmian statutu Spółki w rejestrz…
Polish 4.4 KB
2024-05-07 18:29
Informacja o liczbie akcji i głosów
Polish 74.3 KB
2024-05-07 18:29
Klauzula informacyjna o przetwarzaniu danych osobowych
Polish 174.2 KB
2024-05-07 18:29
Formularz głosowania przez pełnomocnika
Polish 160.9 KB
2024-05-07 18:29
Formularze pełnomocnictwa
Polish 115.1 KB
2024-05-07 18:29
Zestawienie zmian statutu
Polish 86.8 KB
2024-05-07 18:29
Opinia Zarządu
Polish 73.1 KB
2024-05-07 18:29
Projekty uchwał wraz z uzasadnieniem
Polish 148.9 KB
2024-05-07 18:29
Ogłoszenie o zwołaniu NWZ
Polish 145.2 KB
2024-05-07 18:29
Zwołanie NWZ na dzień 3 czerwca 2024 roku - Content (PL)
Polish 2.1 KB
2024-05-07 17:38
Przyjęcie planu budowy wielkoskalowej wytwórni komórek macierzystych i sposobu …
Polish 5.4 KB
2024-04-26 17:12
Podpisy do opinii biegłego rewidenta z badania Sprawozdania Finansowego Biocelt…
Polish 10.3 KB
2024-04-26 17:12
Opinia biegłego rewidenta z badania Sprawozdania Finansowego Bioceltix S.A. za …
Polish 2.9 MB
2024-04-26 17:12
Podpisy do Raportu okresowego rocznego Bioceltix S.A. za rok 2023
Polish 20.9 KB

Automate Your Workflow. Get a real-time feed of all Bioceltix S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bioceltix S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bioceltix S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CAREGEN CO.,LTD. Logo
Develops biomimetic peptides and growth factors for aesthetic and medical solutions.
South Korea
214370
Caribou Biosciences, Inc. Logo
Clinical-stage biopharma developing genome-edited allogeneic cell therapies.
United States of America
CRBU
Carisma Therapeutics Inc. Logo
A clinical-stage biotech developing engineered macrophage-based therapeutics for cancer.
United States of America
CARM
Carna Biosciences, Inc. Logo
Clinical-stage biopharma developing small molecule kinase inhibitors.
Japan
4572
Cartesian Therapeutics, Inc. Logo
A clinical-stage company developing mRNA-engineered cell therapies for autoimmune diseases.
United States of America
RNAC
CASI Pharmaceuticals, Inc. Logo
Biopharmaceutical firm developing therapeutics for organ transplant and autoimmune diseases.
United States of America
CASI
CATALYST PHARMACEUTICALS, INC. Logo
Biopharmaceutical company commercializing drugs for rare neurological and autoimmune diseases.
United States of America
CPRX
cbdMD, Inc. Logo
Producer and distributor of health and wellness CBD products from U.S.-grown hemp.
United States of America
YCBD
CDT Equity Inc. Logo
A clinical-stage biopharmaceutical firm advancing assets for unmet medical needs.
United States of America
CDT
CELADON PHARMACEUTICALS PLC Logo
Researches, cultivates, and manufactures cannabinoid-based medicines for chronic pain.
United Kingdom
CEL

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.